TY - JOUR
T1 - Metastasis: cancer cell's escape from oxidative stress.
AU - Pani, Giovambattista
AU - Galeotti, Tommaso
AU - Chiarugi, Paola
PY - 2010
Y1 - 2010
N2 - According to a "canonical" view, reactive oxygen species (ROS) positively
contribute, in different ways, to carcinogenesis and to malignant progression of
tumor cells: they drive genomic damage and genetic instability, transduce, as
signaling intermediates, mitogenic and survival inputs by growth factor receptors
and adhesion molecules, promote cell motility and shape the tumor
microenvironment by inducing inflammation/repair and angiogenesis.
Chemopreventive and tumor-inhibitory effects of endogenous, diet-derived or
supplemented antioxidants largely support this notion. However, emerging lines of
evidence indicates that tumor cells also need to defend themselves from oxidative
damage in order to survive and successfully spread at distance. This "heresy" has
recently received important impulse from studies on the role of antioxidant
capacity in cancer stem cells self-renewal and resistance to therapy;
additionally, the transforming activity of some oncogenes has been unexpectedly
linked to their capacity to maintain elevated intracellular levels of reduced
glutathione (GSH), the principal redox buffer. These studies underline the
importance of cellular antioxidant capacity in metastasis, as the result of a
complex cell program involving enhanced motility and a profound change in energy
metabolism. The glycolytic switch (Warburg effect) observed in malignant tissues
is triggered by mitochondrial oxidative damage and/or activation of
redox-sensitive transcription factors, and results in an increase of cell
resistance to oxidants. On the other hand, cytoskeleton rearrangement underlying
cell motile and tumor-aggressive behavior use ROS as intermediates and are
therefore facilitated by oxidative stress. Along this line of speculation, we
suggest that metastasis represents an integrated strategy for cancer cells to
avoid oxidative damage and escape excess ROS in the primary tumor site, explaning
why redox signaling pathways are often up-regulated in malignancy and metastasis.
AB - According to a "canonical" view, reactive oxygen species (ROS) positively
contribute, in different ways, to carcinogenesis and to malignant progression of
tumor cells: they drive genomic damage and genetic instability, transduce, as
signaling intermediates, mitogenic and survival inputs by growth factor receptors
and adhesion molecules, promote cell motility and shape the tumor
microenvironment by inducing inflammation/repair and angiogenesis.
Chemopreventive and tumor-inhibitory effects of endogenous, diet-derived or
supplemented antioxidants largely support this notion. However, emerging lines of
evidence indicates that tumor cells also need to defend themselves from oxidative
damage in order to survive and successfully spread at distance. This "heresy" has
recently received important impulse from studies on the role of antioxidant
capacity in cancer stem cells self-renewal and resistance to therapy;
additionally, the transforming activity of some oncogenes has been unexpectedly
linked to their capacity to maintain elevated intracellular levels of reduced
glutathione (GSH), the principal redox buffer. These studies underline the
importance of cellular antioxidant capacity in metastasis, as the result of a
complex cell program involving enhanced motility and a profound change in energy
metabolism. The glycolytic switch (Warburg effect) observed in malignant tissues
is triggered by mitochondrial oxidative damage and/or activation of
redox-sensitive transcription factors, and results in an increase of cell
resistance to oxidants. On the other hand, cytoskeleton rearrangement underlying
cell motile and tumor-aggressive behavior use ROS as intermediates and are
therefore facilitated by oxidative stress. Along this line of speculation, we
suggest that metastasis represents an integrated strategy for cancer cells to
avoid oxidative damage and escape excess ROS in the primary tumor site, explaning
why redox signaling pathways are often up-regulated in malignancy and metastasis.
KW - cancer
KW - inflammation
KW - metastasis
KW - reactive oxygen species
KW - cancer
KW - inflammation
KW - metastasis
KW - reactive oxygen species
UR - http://hdl.handle.net/10807/4348
U2 - 10.1007/s10555-010-9225-4
DO - 10.1007/s10555-010-9225-4
M3 - Article
SN - 0167-7659
VL - 29
SP - 351
EP - 378
JO - CANCER METASTASIS REVIEWS
JF - CANCER METASTASIS REVIEWS
ER -